Regeneron Pharmaceuticals has announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review a new Biologics License Application (BLA) for REGN-EB3, an investigational triple antibody treatment for Ebola
MorePentagon official Andrew Weber discussed global biosecurity scenarios and measures during a panel discussion held at the Aspen Security Forum last week in Colorado, DoD News reported Monday. Cheryl Pellerin writes that Weber – assistant
More